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Abstract
In April 2014, the American Journal of Transplantation published a report on the first lung 
transplant in the United States recovered from an uncontrolled donation after circulatory 
determination of death donor (uDCDD), assessed by ex vivo lung perfusion (EVLP). The article 
identified logistical and ethical issues related to introduction of lung transplant from uDCDDs. In 
an open clinical trial, we have Food and Drug Administration and Institutional Review Board 
approval to transplant lungs recovered from uDCDDs judged suitable after EVLP. Through this 
project and other experiences with lung recovery from uDCDDs, we have identified solutions to 
many logistical challenges and have addressed ethical issues surrounding lung transplant from 
uDCDDs that were mentioned in this case report. Here, we discuss those challenges, including 
issues related to recovery of other solid organs from uDCDDs. Despite logistical challenges, 
uDCDDs could solve the critical shortage of lungs for transplant. Furthermore, by avoiding the 
deleterious impact of brain death and days of positive pressure ventilation, and by using 
opportunities to treat lungs in the decedent or during EVLP, lungs recovered from uDCDDs may 
ultimately prove to be better than lungs currently being transplanted from conventional brain-dead 
organ donors.
Introduction
In the American Journal of Transplantation, Suzuki et al (1) described the first lung 
transplant performed in the United States after recovery from a Maastricht Category 2 
uncontrolled donation after circulatory determination of death (uDCDD) donor assessed by 
ex vivo lung perfusion (EVLP). The authors posit that the potential role of uDCDD donors 
(uDCDDs) as a donor source should be “reconsidered,” and pose logistical and ethical 
hurdles that require attention. We are actively working to perform lung transplants from 
uDCDDs. In September 2013, we began an NIH-funded Phase II clinical trial, “Ex-vivo 
Perfusion and Ventilation of Lungs Recovered from Non-Heart-Beating Donors to Assess 
Transplant Suitability” (www.clinical-trials.gov, NCT01615484). Based on our experience 
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with lung recovery from uDCDDs, we offer solutions to the ethical and logistical issues 
cited in the case report.
Limitations of Conventional Donors to Provide Enough Lungs
The number of conventional brain-dead donors is inadequate to meet the need for all patients 
with end-stage lung disease who could benefit from lung transplant. Despite efforts to 
increase donor numbers, numbers of brain-dead donors have decreased in many countries. 
Aspiration at the time of brain injury leads to pneumonia in many conventional brain-dead 
donors. Without an immune system, EVLP is unlikely to resolve pneumonia in a donor lung. 
Neurogenic pulmonary edema is common after severe brain injury (2); this might be 
improved with EVLP. Although controlled donation after circulatory determination of death 
(cDCDD) donors have not been well utilized for lung transplant, the number of cDCDD 
donors is relatively small.
Potential of EVLP to Further Increase Lung Donors
EVLP has been used to increase the yield of lungs from conventional brain-dead organ 
donors (3), but its impact will be limited by the size of this donor pool, and the 
pathophysiology of lung injury in these donors. EVLP could substantially increase the 
number of available lungs if used to assess suitability of lungs for transplant recovered from 
uDCDDs, both Category 1 (sudden deaths outside of hospital) and Category 2 (sudden 
deaths within the hospital). The number of these potential lung donors has not been well 
studied. The AmericanHeart Association estimates thereare over 200 000 cardiac arrests 
outside of hospital treated by Emergency Medical Services (EMS) personnel, with only 12% 
obtaining a rhythm and being transported. The median age is 60. How many of these over 80 
000 potential uDCDDs would be suitable for lung transplant is unknown. There are almost 
as many in-hospital cardiac arrests; likely a smaller percentage of hospitalized patients 
would be suitable lung donor candidates. However, uDCDDs might provide thousands more 
lung donors. This contrasts with the 1800 lung transplants currently performed annually in 
the United States. Lung transplant is expensive, as are many life-prolonging therapies, 
including other organ transplants and cancer therapies. However, long-term survival and 
improved quality of life after lung transplant exceed many therapies for cancer patients. 
Ultimately, choices about resource allocation in health care may be necessary.
uDCDDs in Spain
Based on “presumed consent,” organ recovery from uDCDDs has been routine in Spain for 
over a decade. All Spanish citizens are presumed organ donors unless they have specifically 
declined participation. Consent is still sought from next-of-kin (NOK). According to Rafael 
Matesanz, M.D., Director of Spain’s Organización Nacional de Trasplantes (ONT), 93% of 
NOK consent to organ donation (Dr. Matesanz, personal communication, Madrid, Spain, 
March 19, 2014).
In some Spanish cities, after cardiopulmonary resuscitation (CPR) is determined to be futile, 
potential uDCDDs are placed on a CPR machine, ventilated and transported to a hospital 
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with organ procurement surgeons. At the hospital, CPR and ventilation are stopped for 5 
min, and death is declared by emergency department (ED) physicians. Then, physicians 
place cannulae via groin vessels to initiate perfusion and cooling of the abdominal organs, 
an occluding balloon in the descending thoracic aorta to prevent cerebral blood flow, and 
chest tubes to instill cold solutions into the pleural spaces to cool the lungs. NOK are 
contacted; they have the opportunity to deny organ recovery, but usually agree and organ 
recovery proceeds. In Spain, this has resulted in 67 lung transplants from uDCDDs since 
2002 (Elisabeth Coll, personal communication, ONT, Madrid, October 13, 2014). Lung 
assessment techniques have been variable, as has been the use of EVLP.
uDCDDs in the United States
One ethical concern is the possibility of cerebral perfusion by CPR during transportation of 
potential uDCDDs to the hospital before death is declared. This is a substantial challenge to 
use of uDCDDs for organ recovery in the United States. Because death is defined as 
irreversible cessation of respiratory and circulatory functions (4), a panel convened by the 
Health Resources and Services Administration (HRSA) concluded that resumption of 
circulation by any means, including CPR to maintain integrity of organs for transplant, could 
not be sanctioned at any time (5). This dilemma could be resolved by changing either the 
notion that death must occur before organ recovery (6) or the notion of irreversibility (7) or 
functions, particularly from individuals who provide first-person consent.
Potential of uDCDD Donors in Lung Transplant
Aside from increasing the number of lungs for transplant, uDCDDs may offer other 
advantages. Because brain death is associated with up-regulation of innate immunity in the 
donor and a “cytokine storm” (8,9), and brain-dead donors require prolonged positive 
pressure ventilation, which contributes to lung injury, lungs recovered from uDCDDs might 
function better than lungs recovered from brain-dead donors, currently being transplanted. 
Furthermore, EVLP offers opportunities to treat donor lungs, to allow recovery from the 
antecedent warm ischemic insult and possibly modify the lung to reduce IRI (10). We and 
others showed that ventilation of rat lungs in an NHBD with nitric oxide (11) or carbon 
monoxide (500 ppm) (12,13) improved lung function after transplant.
Logistical Challenges to Lung Recovery From uDCDDs
In their case report, Suzuki et al allude to logistical and ethical challenges that require 
address before lung recovery from uDCDDs can become established practice, stating that 
“[…] expansion of the lung allograft pool through uDCDDs is perceived to be associated 
with nonquantifiable risks” (14), and “The hesitation for use of lungs through uDCDDs 
stems mainly from medical concerns over secondary injury from prolonged warm ischemia 
[…].” Many of these challenges have already been identified and addressed. As confidence 
in EVLP as a method to assess suitability of lungs for transplant accumulates, we believe 
that we have a tool to assess suitability of lungs recovered from uDCDDs. EVLP allows 
assessment of gas exchange and compliance over time, palpation, bronchoscopy and 
radiography.
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The authors comment that topical cooling was a “critically important adjunct to restrict 
warm ischemic time.” It is not clear whether topical cooling is critical. In a porcine study, 
Rega et al (15) showed that topical cooling for 3 h was superior to ventilation for 3 h, when 
lungs were perfused in a circuit, but both interventions were instituted after 1 h of 
nonventilated warm ischemia. So for the relatively short time before hypothermic Perfadex 
flush to cool the lungs, static inflation or continued ventilation may have maintained lung 
viability. Based on our animal data (16–18), we believe that 1 h of nonventilated and 2 h of 
ventilated ischemia would be well tolerated. Nakajima et al (19) showed in a canine model 
that EVLP for 3.5 h with Steen solution resulted in excellent lung function after transplant 
following 4 h of nonventilated warm ischemia.
We agree that organ recovery from uDCDDs has substantial logistical challenges. After an 
earlier uDCDD project, we focused on cooperation from EMS workers (20). As first 
responders, EMS professionals are gatekeepers to uDCDDs. In the last decade, there has 
been an important shift in EMS responsibilities, with death declaration in the field by trained 
EMS staff. Medical examiners are contacted for permission to move the body, but currently 
there is no urgency. Police have become accustomed to viewing the deceased at the scene, 
rather than finding out about failed resuscitation after a decedent was taken to a hospital.
When we started recovering lungs from uDCDDs for this project, Deborah Radisch, M.D., 
medical examiner for Wake County, NC (also state medical examiner and a UNC faculty 
member), was enthusiastically supportive. She instructed her staff to authorize immediate 
movement of the potential uDCDD unless EMS suspected foul play and requested law 
enforcement review of the scene. Because they were accustomed to viewing the deceased at 
the scene, police objected to this “new” practice. This led to a hiatus until we met with 
leadership in the Wake County district attorney’s office. That office also supported the 
project, and agreed that in years past, decedents had been moved from the scene to EDs, 
where they were pronounced dead if CPR was unsuccessful. The Wake County district 
attorney’s office, with the state medical examiner’s assistance, wrote a memorandum to all 
police precincts in Wake County, authorizing rapid transportation of the deceased. Our 
medical examiner has authorized removal of decedents from motor vehicle crashes provided 
that blood and urine are collected for toxicology. We routinely recover and store this on all 
uDCDD cases. The remaining logistical hurdle is identifying and informing NOK of motor 
vehicle crash victims. We agree with Suzuki et al that “it is important that medical 
examiners and coroners are educated regarding uDCDD and protocols are put in place for 
the preservation of any needed forensic evidence.” This can be done and has been done here.
Through interaction with EMS staff in several North Carolina (NC) counties, we learned that 
EMS staff were not comfortable approaching NOK about organ donation, but were very 
engaged in facilitating contact between the NOK and the organ procurement organization 
(OPO) (20). Accordingly, when CPR is terminated and death is declared, NOK is informed 
of the death and then told to expect a few phone calls, including from Carolina Donor 
Services (CDS). Minimizing warm ischemia is critically important. There are many 
logistical hurdles to address that can help achieve acceptable warm ischemic times. 
Although blood type, serologies, and HLA are not available at the time of lung recovery 
from uDCDDs, blood withdrawn during lung recovery can be sent for expeditious typing. 
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EVLP can be started at a time to coincide with its termination when serology results are 
available.
Our protocol for lung recovery is outlined in Figure 1. CDS is called for decedents in Wake 
County or participating EDs. NOK is identified by EMS or the ED, informed of the death, 
and told to expect some routine phone calls. A trained CDS requestor contacts NOK, using 
one of two scripts, depending on donor first-person consent status. If NOK are not available 
or cannot be located, the case is abandoned after 2 h. When NOK are contacted, they are 
consoled and asked if, or informed that, the decedent wanted to donate organs. They are told 
that there is an NIH-sponsored study to evaluate lungs recovered after death and that suitable 
lungs could be transplanted. If NOK assent, screening questions are asked as depicted in 
Figure 1. If suitable, CDS explains they will call back later for a more detailed medical/
social history (med/soc). CDS calls EMS or ED to initiate ventilation and arranges transport 
to CDS’ operating room or to UNC Hospitals, where the first available OR is made 
available. The project PI is called. A donor surgeon is located and a team is mobilized to 
recover the lungs. CDS call center staff obtain a detailed med/soc from NOK. Lungs are 
recovered in the standard fashion. Subcarinal nodes are recovered for HLA typing. Donor 
blood is aspirated from the right atrium/IVC for blood type, culture, HLA, toxicology and 
serologies. After ABO typing, a match list is run by CDS. EVLP is performed in a Class II 
hood, begun so that 4-h EVLP will be completed when serology results are available. After 
EVLP, lungs are cooled, flushed with cold Perfadex, packaged as lungs are from a 
conventional donor, and an ex vivo CT scan is performed. Suitable lungs are transplanted 
into consented recipients.
Impact of First-Person Consent
First-person authorization via the establishment of online state donor registries puts an 
entirely new slant on the process of organ recovery from uDCDDs. Forty-eight states have 
now revised their Uniform Anatomical Gift Act (UAGA) to allow first-person authorization 
to be a legal consent to donate organs. Although many OPOs are reluctant to proceed with 
organ recovery without NOK assent, it is not legally required if first-person authorization is 
in place. The NC Attorney General’s office agrees that our OPO does not require NOK 
consent to proceed with lung recovery from registered organ donors. The NC law states “If 
an anatomical gift has been or might be made of a body part of a decedent […] the medical 
examiner and procurement organization shall cooperate in the timely removal of the body 
part from the decedent for the purpose of transplantation, therapy, research, or education” 
(21). According to Sheldon Kurtz, JD, who wrote the first draft of the UAGA and was 
reporter for the committee that finalized the draft circulated to states for approval, the act 
requires the OPO to recover solid organs from consented decedents if the intent is transplant. 
NOK consent is not required, and delay to find NOK is unnecessary (Sheldon Kurtz, 
personal communication, University of Iowa, December 2, 2014). The NC Attorney 
General’s office is considering this interpretation. CDS remains unwilling to recover lungs 
without NOK consent. Some OPOs (Ohio and New Jersey) have proceeded with organ 
recovery from brain-dead donors under first-person consent, over NOK objections. The New 
Jersey OPO resorted to obtaining a court order authorizing organ recovery. Several eye 
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banks, including NC’s, do not require NOK consent. If NOK cannot be located within 6 h, 
corneas are recovered from registered organ and tissue donors.
Suzuki et al are concerned that “families may be mistrustful of the health care team if they 
are notified of the patient’s death after the organs have already been retrieved.” As a 
practical matter, NOK assent can be obtained before transplant or even before evaluation 
occurs. However, the law requires timely removal of organs for the purpose of preservation 
for transplant, and transplantation if the organs are suitable and there is a potential recipient. 
If explained in this light, and that recovery was performed to honor the wishes of the 
decedent, we believe that the public will accept the concept. Perhaps additional public 
education is required. NOK will need to provide essential information regarding details of a 
med/soc history, so their participation in the process is necessary. Thus, NOK would have an 
opportunity to refuse transplantation, even if the decedent consented and organs were 
recovered. A recent study suggests that the vast majority of OPOs in the United States 
believe that first-person authorization should be honored (22). The UAGA requires lung 
recovery from consented donors, even before NOK are found and informed of the death.
Ethical Issues in uDCDDs
Some of the concerns raised by Suzuki et al related to ethical issues are perhaps misplaced. 
There is no concern about the dead donor rule (23) in the scenario of lung-only recovery 
from an uDCDD, because the individual’s death has been determined before any 
intervention begins.
Lung ventilation in an uDCDD poses no risk for auto-resuscitation or restoration of brain 
stem function, because systemic blood flow is not restored. Ventilation will not interfere 
with the permanence of cessation of circulation, a point of contention for recovery of other 
organs from uDCDDs (5). Suzuki et al reflect that “greater ethical consensus on how and 
when death may be declared may be needed before the pool of potential uDCDDs can be 
utilized in the United States.” While this may be true for resuming circulation to preserve 
abdominal organs, this concern does not exist when a decedent’s body is ventilated for lung 
recovery.
Ethical concerns also emerge from consideration of interventions upon the body after death. 
The passage of laws that address recovery with first-person consent indicates a growing 
consensus about the acceptability of the practice, so ethical concerns about ventilation after 
death may abate. Intent to seek consent from NOK before recovery may further reassure the 
public about a trustworthy practice. Mechanical ventilation is a routine part of CPR. The 
decision to terminate CPR and ventilation is based on a decision that death has occurred. 
Even without first-person authorization, continued mechanical ventilation postmortem until 
NOK is contacted may not pose an ethical dilemma. Our research project/clinical trial 
adheres to accepted principles of ethical conduct of research on the recently deceased (24).
Summary
The logistical issues surrounding the potential use of uDCDDs as lung donors have been 
addressed in our local area. Improvement to minimize ischemic time is still possible. 
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Because jurisdiction over sudden deaths, EMS response, and medical examiner practices 
vary within states and even within counties and cities, the widespread practice of lung 
recovery from uDCDDs will require education of various stakeholders. The remaining 
ethical issues relate to consideration of how we respect the preferences of the decedent and 
of NOK regarding organ donation in a process that engenders societal trust. There are still 
substantial obstacles to timely recovery of lungs for transplant evaluation. Many decedents 
lack identification, or NOK is hard to locate, or too grief-stricken to discuss donation. We 
are learning that many potential donors have co-existing medical conditions that preclude 
safe lung transplant. In 15 months, we have recovered 16 lung blocks; 8 had EVLP. Seven 
were not suitable for transplant; one was suitable, but no consented appropriate recipient was 
available. We are continuing to encounter and address obstacles to timely uDCDD recovery 
and are convinced that uDCDDs are a potentially important source of lungs for transplant. 
Recovery of other organs for transplantation from uDCDDs in the United States may require 
changes in law or policy with regard to the dead donor rule and definition of death. This is 
appropriate, given that half of US adults have indicated a desire to donate their organs for 
transplant. There is a moral obligation to attempt to honor that wish.
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Figure 1. Schema for current clinical trial at UNC (NCT01615484) to evaluate lungs recovered 
from uDCDDs
Eligible individuals are under age 66 not successfully resuscitated after CPR or died in the 
emergency department (ED). Circumstances that require law enforcement investigation are 
ruled out (r/o). Many potential donors are r/o for medical reasons. After EVLP and ex vivo 
CT scan, suitable lungs are offered to consented recipients. Procedures that would reduce 
ischemic time if first-person consent is honored. &hearts;, Procedures where improved 
logistics will reduce ischemic time.
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